- Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trialCherri Miner
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA
Clin Ther 24:417-33. 2002..Because the symptoms of premenstrual dysphoric disorder (PMDD) are limited to the luteal phase of the menstrual cycle, the potential benefit of luteal-phase dosing has been hypothesized...
- Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diariesLee S Cohen
Perinatal Psychiatry Clinical Research Program, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA
Obstet Gynecol 100:435-44. 2002..To evaluate premenstrual daily dosing with fluoxetine for treatment of premenstrual dysphoric disorder...